FINANCIAL

In 2025, Bondalti reaffirmed the strength of its economic and financial structure, demonstrating high resilience in a challenging macroeconomic environment. The company closed the fiscal year with consolidated revenue of 385 million euros, a performance that reflects the strength of its core businesses. EBITDA stood at 56 million euros, demonstrating the maintenance of healthy operating margins and rigorous cost management.

The company’s financial health is evident in the performance of its key balance sheet indicators. Bondalti Capital ended the year with consolidated net debt of 93 million euros, while the financial autonomy ratio rose to 91.9% (compared to 91.7% in 2024), confirming a solid capital structure capable of supporting ambitious investment cycles.

The year was marked by decisive progress in the tender offer for the Spanish company Ercros.

To finance this transaction and optimize its capital structure, Bondalti Chemicals secured a 405.5 million euro loan, which includes the refinancing of existing debt. With the completion of the tender offer in early 2026 (securing more than 77% of the voting rights), these financing terms took full effect.

This robust performance, combined with rigorous cash management—which kept collection and payment cycles in line with historical standards—provides Bondalti with the stability needed to lead the industrial transition and consolidate its new international presence.